Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01274611 · ClinicalTrials.gov registry record · NA
Botox and Suction-Curettage for Treatment of Excessive Underarm Sweating (Axillary Hyperhidrosis)
A NA study of Axillary Hyperhidrosis, sponsored by Northwestern University.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT01274611 is a NA study of Axillary Hyperhidrosis that has completed, run by Northwestern University. The registered enrollment target is 20 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01274611, a NA study of Axillary Hyperhidrosis, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to compare the effectiveness of two methods in the treatment of excessive underarm sweating (axillary hyperhidrosis): suction-curettage and Botox injections. Suction-curettage is a method in which the doctor will insert a suction tool into two small incisions in order to suction out the sweat-producing glands. It is similar to liposuction, but instead of suctioning out fat, the doctor suctions out the layer of the deep skin where the sweat glands are located. This method has been shown in some studies to effectively reduce underarm sweating for months at a time. Botox is a Food and Drug Administration (FDA) approved drug that in small doses, paralyses muscles. It is most commonly and famously used in the treatment of facial wrinkles. However, it has also been approved to treat excessive sweating. When injected in areas that sweat excessively, sweating can be significantly reduced in that area for months at a time. This study is a pilot study designed to determine feasibility of these procedures.
Conditions Studied
Interventions
- DRUG Botulinum Toxin Type A
- DEVICE Suction-Curettage
Study Locations (1)
Illinois
- Northwestern University Feinberg School of Medicine, Department of Dermatology - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2010-12 |
| Est. Completion | 2011-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01274611
The ClinicalTrials.gov registry entry for NCT01274611 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Axillary Hyperhidrosis appearing as the primary indexed condition, and to 2 interventions - of which Botulinum Toxin Type A is the first listed.
NCT01274611 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT01274611 about?
NCT01274611 is a clinical study titled "Botox and Suction-Curettage for Treatment of Excessive Underarm Sweating (Axillary Hyperhidrosis)". The purpose of this study is to compare the effectiveness of two methods in the treatment of excessive underarm sweating (axillary hyperhidrosis): suction-curettage and Botox injections. Suction-curettage is a method in which the doctor will insert a suction tool into two small incisions in order to...
What is the current status of trial NCT01274611?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2010-12. Estimated completion is 2011-12.
What conditions does trial NCT01274611 study?
This clinical trial studies the following conditions: Axillary Hyperhidrosis.
What interventions are being tested in trial NCT01274611?
The interventions under investigation include: Botulinum Toxin Type A (DRUG), Suction-Curettage (DEVICE).
Who is sponsoring clinical trial NCT01274611?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01274611 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.